As analyst coverage remains a challenge for many listed companies, the debate around issuer-sponsored research is increasingly focused on a crucial question: how can investors access meaningful analysis while maintaining confidence in its independence?
Equity research plays an important role in helping investors understand businesses, assess valuations and identify opportunities across the stock market. Yet the way research is funded has become an increasingly important part of the conversation, particularly for companies that struggle to attract traditional analyst coverage.
In a recent article, Who Pays for Research Matters. How It Is Produced Matters More, Jason Paltrowitz, Principal at European Equity Research Partners (EERP), argues that investors should look beyond a research provider’s funding model and examine the safeguards that underpin its work.
The distinction is important. Research can be funded by brokers, subscriptions or the companies being analysed, but none of these arrangements automatically guarantees quality or independence.
The challenge of sponsored research
For many listed companies, particularly those outside the largest indices, obtaining meaningful analyst coverage can be difficult. Without accessible research, investors may have fewer opportunities to understand a company’s operations, financial position, valuation and long-term strategy.
Issuer-sponsored research offers one potential route to addressing this gap. However, because the company pays for the analysis, questions around conflicts of interest and editorial independence are inevitable.
As Paltrowitz highlights, the key distinction is whether a company is paying for coverage or effectively buying a favourable opinion.
Credible research must allow analysts to examine both the opportunities and the risks, supported by transparent assumptions, clear valuation methodologies and appropriate disclosures.
Transparency is essential for investor confidence
The funding arrangement is only one part of the picture. Investors also need to understand how analysts are appointed and remunerated, whether commercial teams can influence conclusions, and what happens when the evidence contradicts management’s expectations.
Clear separation between factual review and editorial control is particularly important. Companies should be able to correct factual inaccuracies without having the ability to remove legitimate criticism or dictate an analyst’s conclusions.
Equally, investors need access to the assumptions behind forecasts and target prices, including the potential impact of changes in revenue, margins, financing requirements and execution.
These principles help readers judge the strength of the analysis for themselves rather than relying solely on a provider’s reputation or a report’s headline conclusion.
A changing framework for equity research
The regulatory framework for issuer-sponsored research is also evolving. The European Union’s code of conduct, established under Commission Delegated Regulation (EU) 2026/1092 and in force since 7 September 2026, sets out requirements addressing conflicts of interest, objectivity, independence and disclosure. The regulation and its requirements form part of the wider debate around standards in this area.
However, compliance alone cannot establish whether a report represents good analysis. Investors must still be able to examine the evidence, understand the methodology and challenge the conclusions.
For listed companies, the objective should be to make their businesses easier to understand and evaluate, not simply to secure a positive research report.
For investors, the priority is access to information that is transparent, balanced and sufficiently detailed to support independent decision-making.
Research must earn its credibility
The debate around equity research should ultimately move beyond the question of who funds it. What matters is whether the process protects analytical independence, whether the evidence supports the conclusions and whether the provider remains accountable when circumstances change.
For companies seeking greater investor awareness, professionally produced research can help explain their business and provide context for the investment case. Its long-term value, however, depends on investors being able to trust the process behind it.
As the equity research landscape continues to evolve, transparency, robust methodology and the freedom to publish an honest conclusion will remain central to building that trust.
To learn more about European Equity Research Partners’ approach to issuer-sponsored research and the standards governing its work, contact Jason Paltrowitz [email protected], Principal at EERP.
Leave a Reply